Glycosylated Carcinoembryonic Antigen CGM2 (176-186)

overview | features and specs | data sets | literature

Product Overview
Protea's Glycopeptide Standards are lyophilized peptides that are useful for the standardization and method development of glycoproteomic analyses. Glycosylated Carcinoembryonic Antigen CGM2 (176-186) (#PS-502) contains 500 pmol of carcinoembryonic antigen CGM2 (176-186) with a glycosylated asparagine at position 183 (8th residue of peptide). Protea also offers a non-glycosylated peptide partner standard (#PS-605) that contains 500 pmol of non-glycosylated carcinoembryonic antigen CGM2 (176-186). Each Glycopeptide Standard is Certified Mass Spec Grade and provided in convenient, lyophilized vials for easy reconstitution and usage.
Features and Specifications
  • Certified Mass Spec Grade
  • Lyophilized for long shelf-life and easy reconstitution

Research Applications:
  • Method development for glycopeptide mapping studies
  • Internal standard for glycoprotein and glycopeptide analysis
  • Standardization of affinity capture and selective enrichment protocols

Protea's Glycopeptide Standards are provided in a lyophilized format. Each vial of PS-502 contains 500 pmol of total peptide and is batch tested for quality assurance.
Data Sets

(click image(s) above to enlarge)
***Please to download documentation.

Glycosylated Carcinoembryonic Antigen CGM2 (176-186) Availability
Glycosylated Carcinoembryonic Antigen CGM2 (176-186)
500 pmol
***this product must be shipped cold, requiring 1 or 2 day shipping
PS-502-11$78.00add to cart
Glycosylated Carcinoembryonic Antigen CGM2 (176-186)
3 x 500 pmol
***this product must be shipped cold, requiring 1 or 2 day shipping
PS-502-33$198.90add to cart

Recently Viewed Products:

Glycosylated Carcinoembryonic Antigen CGM2 (176-186)

...innovation for bioanalytics